Bacterial News and Research

RSS

Antibiotic moxifloxacin as a new treatment for tuberculosis

Moxifloxacin is currently approved in more than 100 countries, including the United States, as a treatment for bacterial respiratory infections, such as bronchitis, sinusitis and pneumonia.

17 Oct 2005

Researchers find new type of antibiotic against the cholera bacteria

Just as hurricanes in the Gulf states and Guatemala have raised the risks of cholera outbreaks, researchers at Harvard Medical School have identified a new type of antibiotic against the cholera bacteria.

16 Oct 2005

New fungal defensin, plectasin, possesses as much power as penicillin

A peptide identified in a fungus found in northern European pine forests possesses as much power as penicillin as well as vancomycin, according to an international team of researchers.

12 Oct 2005

Why the human immune system does not function well in the weightlessness of space

Researchers at the San Francisco VA Medical Center have identified a set of key immune-response genes that do not turn on in a weightless environment. The discovery is another clue in the effort to solve an almost 40-year-old mystery

12 Oct 2005

Fijiian seaweed shows potential to kill cancer cells, bacteria and the HIV virus

Researchers have discovered 10 new molecular structures with pharmaceutical potential in a species of red seaweed that lives in the shallow coral reef along the coastline of Fiji in the south Pacific Ocean.

12 Oct 2005

Nabi Biopharmaceuticals granted Staphylococcus Antigen and Vaccine patent

Nabi Biopharmaceuticals has announced that it has been granted U.S. Patent No. 6,936,258 entitled "Staphylococcus Antigen and Vaccine" by the U.S. Patent and Trademark Office for the composition of a strategically important glycoprotein-based antigen (GP-1) associated with three Staphylococcal strains: S. epidermidis, S. haemolyticus and S. hominis.

11 Oct 2005

New technique to produce large numbers of antibodies quickly

Faster method to create antibodies for disease research British scientists are pioneering a new technique to produce large numbers of antibodies quickly and reliably to help the study of dangerous bacteria.

9 Oct 2005

Bacteria of different species can talk to each other using a common language

The interspecies crosstalk and misdirection could have important consequences for human health, said Bonnie L. Bassler, an HHMI investigator at Princeton University whose study was published in the September 29, 2005, issue of Nature.

4 Oct 2005

Discovery of mechanism in the body that could lead to autoimmune diseases

Researchers at National Jewish Medical and Research Center have discovered a mechanism in the body that could lead to autoimmune diseases, such as lupus, rheumatoid arthritis, or diabetes.

3 Oct 2005

Salivary antimicrobial peptide expression and dental caries experience in children

A study comparing antimicrobial peptides, or AMPs, a group of small proteins that occur naturally in human saliva and act like antibiotics against oral bacteria, could lead to new ways to screen children for risk of tooth decay and protect them against this common, chronic problem.

28 Sep 2005

Discovery may lead to development of more effective antibiotics

Researchers at the Georgia Institute of Technology and the John Innes Centre in the United Kingdom have uncovered a mechanism with which disease-causing bacteria may thwart the body's natural defense responses. The findings, which could ultimately lead to the development of more effective antibiotics, appear in the September 29, 2005 issue of the journal Nature.

28 Sep 2005

100 year old technology to fight MRSA

A technique that has been around for more than one hundred years is being used in new research as a way of killing methicillin-resistant Staphylococcus aureus (MRSA) using light. The research to be reported today at the British Pharmaceutical Conference in Manchester, is being undertaken by researchers from Queen's University Belfast.

28 Sep 2005

Clostridium botulinum exposed

A discovery by Institute of Food Research (IFR) scientists is set to improve the food industry’s ability to predict foodborne botulism.

28 Sep 2005

Robots to shed light on sexual disease

It won’t be long before automated DNA test contribute to providing more knowledge about the up to now nearly unknown sexually transmitted mycoplasma – truly more widespread than chlamydia. Mycoplasma is a bacterial infection of the genitals.

28 Sep 2005

Equine flu virus jumps to dogs

A Cornell University virologist has isolated a highly contagious equine flu virus that is spreading a sometimes-fatal respiratory flu among dogs, and is responsible for a major dog-flu outbreak in New York state. There is no evidence that the virus could infect people.

27 Sep 2005

Wound dressing to stop antibiotic-resistant bacteria from spreading

University of Florida researchers have led the development of a new type of wound dressing that could keep dangerous antibiotic-resistant bacteria from spreading in hospitals, a problem that leads to thousands of deaths in the United States each year.

27 Sep 2005

Cancer vaccine based on the bacterium Listeria monocytogenes, can cure mice with breast tumors

A team from the University of Pennsylvania School of Medicine has shown that by using a cancer vaccine based on the bacterium Listeria monocytogenes, they can cure mice with established breast tumors. Cancer vaccines, which are more properly described as immunotherapy, work by boosting an immune response against tumor-associated antigens.

27 Sep 2005

Pneumonia doesn't appear to harm HIV-positive patients any more than those without HIV

In a two-year study that documented cases in 26 hospitals in 11 countries including the United States, Canada, South Africa, Chile and Spain, outcomes for 58 HIV-positive patients with CAP, or community-acquired pneumonia (pneumonia contracted outside of hospitals) were compared with outcomes for 174 HIV-negative patients suffering a similar severity of CAP.

27 Sep 2005

Antibody in humans that quickly fights the smallpox virus

Researchers at the La Jolla Institute for Allergy & Immunology (LIAI) have made a major advancement toward protecting society against a smallpox outbreak by identifying an antibody in humans that quickly fights the smallpox virus.

26 Sep 2005

Increasingly virulent Staph infections

In a "Brief Report" in the 22 September 2005 issue of the New England Journal of Medicine, researchers at the University of Chicago describe three cases of rapidly progressive and ultimately fatal Staphylococcus aureus infections in small children.

26 Sep 2005